The potential of Δ 9 -tetrahydrocannabinol (THC) as a treatment for migraine depends on antinociceptive efficacy with repeated administration. Although morphine has good antinociceptive efficacy, repeated administration causes medication overuse headache (MOH) -a condition in which the intensity/frequency of migraine increases. The present study compared the effect of repeated morphine or THC administration on the magnitude and duration of migrainelike pain induced by a microinjection of allyl isothiocyanate (AITC) onto the dura mater of female rats. Acute administration of THC or morphine prevented AITC-induced depression of wheel running. This antinociception was maintained in rats treated repeatedly with THC, but not following repeated administration of morphine. Moreover, repeated morphine, but not THC administration, extended the duration of AITC-induced depression of wheel running. These data indicate that tolerance and MOH develop rapidly to morphine administration. The lack of tolerance and MOH to THC indicates that THC may be an especially effective long-term treatment against migraine. Behavioural Pharmacology 29: [469][470][471][472]
Introduction
A major limitation of current migraine treatments is the development of medication overuse headache (MOH). MOH is a debilitating disorder characterized by an increase in the intensity and frequency of migraine attacks caused by repeated use of anti-migraine therapies (e.g. triptans, opioids, etc.) (Westergaard et al., 2016) . Thus, novel therapies must be evaluated both for antinociceptive efficacy and resistance to MOH, but challenges in assessing migraine and MOH in laboratory animals have markedly limited the development of new treatments.
Repeated administrations of opioids, triptans, and NSAIDs have been reported to elicit MOH in animal models of migraine (Kopruszinski et al., 2016) . Unfortunately, this study uses tactile allodynia as an indirect method to assess migraine. Activation of dural afferents using the TRPA1 agonist allyl isothiocyanate (AITC) has been used to generate migraine-like pain in rats (Edelmayer et al., 2012) . Our recent finding that a microinjection of AITC onto the dura produces a sumatriptan-reversible depression of home cage wheel running that lasts ∼ 3 h (Kandasamy et al., 2017c) indicates that this is a good model of migraine-like pain.
Survey data indicate that marijuana is a common method of self-medication for migraine pain (Baron, 2015) . We have previously shown that administration of Δ 9 -tetrahydrocannabinol (THC), the primary ingredient in marijuana, prevents migraine-depressed wheel running in female rats (Kandasamy et al., 2018) . Given that migraine patients typically take marijuana on a regular basis, marijuana may be one of the few drugs that does not produce MOH. The present experiment tested this hypothesis by comparing the effects of repeated THC or morphine administration on MOH using home cage wheel running to quantify the magnitude and duration of migraine.
Methods

Subjects
Female Sprague-Dawley rats (50-70 days old) were used because migraine is much more common in women than men. All procedures were approved by the Washington State University Animal Care and Use Committee and were performed in accordance with the International Association for the Study of Pain's Policies on the Use of Animals in Research.
St. Louis, Missouri, USA) could be applied to the dura mater to induce migraine-like pain. Loctite super glue (Loctite Brand, Henkel Corporation, Westlake, Ohio, USA) and dental cement anchored the guide cannula to two screws in the skull. Following surgery, rats were housed individually in a cage with a running wheel (27.9 cm diameter; Kaytee Products Inc.; Kaytee Chilton, Wisconsin, USA) (Kandasamy et al., 2017c) . Wheel revolutions were recorded 23 h/day (Multi-Varimex software; Columbus Instruments, Columbus, Ohio, USA) beginning at the onset of the 12-h dark phase of the light cycle (17:00 h). Rats were allowed unrestricted access to the wheel for 23 h/day for 8 days following surgery.
Baseline wheel running was measured for 23 h on day 8. Then, rats received repeated injections of THC (1.0 mg/kg, intraperitoneal), morphine (3.2 mg/kg, intraperitoneal), or vehicle beginning at 16:45 h on day 9 and continuing twice a day on days 10 and 11 (10:45 and 16:45 h). On day 12, the rat was injected with AITC or mineral oil onto the dura mater, followed immediately by a systemic injection of THC (0.1, 0.32 mg/kg, intraperitoneal), morphine (0.32, 1.0 mg/kg, intraperitoneal), or vehicle. All injections were completed by 16:50 h so activity could be recorded beginning at 17:00 h. This procedure was repeated every other day (days 14 and 16); thus, each rat was tested with both drug doses and vehicle in a counterbalanced order. THC, morphine, or vehicle was administered at 10:45 and 16:45 h on the intervening days (days 13 and 15) to maintain drug exposure. Rats were euthanized 48 h after the last AITC injection.
Drugs AITC (10%) was mixed in mineral oil and injected into the periosteal space in a volume of 10 µl. THC (SigmaAldrich Inc.) was dissolved in vehicle (1 : 1 : 18; ethanol : cremophor : saline) and morphine sulfate (NIDA supply program) was dissolved in saline.
Statistical analysis
Hourly and daily wheel running activity was analyzed as a percent of each rat's baseline value (Kandasamy et al., 2017a (Kandasamy et al., , 2017b . Only rats with a baseline of 400 wheel revolutions or more were included in data analysis (Kandasamy et al., 2016) . Mean SEM wheel running levels during the 3 h period of the AITC-induced migraine were analyzed by one-way and two-way analysis of variances, followed by Bonferroni post-hoc analysis. Statistical significance was defined as a probability of less than 0.05.
Results
Microinjection of AITC onto the dura mater caused a reduction in wheel running that lasted for at least 3 h irrespective of pretreatment (Fig. 1) . Acute administration of 0.32 mg/kg of THC prevented AITC-induced depression of wheel running in both vehicle [F(2, 20) = 10.42, P < 0.001] and THC-pretreated [F(2, 19) = 4.98, P < 0.02] rats compared with rats treated with vehicle or a low dose of THC (0.1 mg/kg) (Fig. 1a) .
In rats pretreated with saline, administration of 1.0 mg/kg of morphine immediately following AITC produced a transient block of AITC-induced depression of wheel running compared with rats administered saline or a low dose of morphine (0.32 mg/kg) (Fig. 1b, top) . Analysis of the magnitude of wheel running during the hour of morphine antinociception indicated significant differences between morphine doses [F(2, 20) = 8.98, P = 0.002], driven by significantly higher levels of wheel running in rats injected with 1.0 mg/kg of morphine compared with 0.32 mg/kg of morphine or saline. This antinociceptive effect of morphine was not evident in rats pretreated with morphine for 2.5 days. Microinjection of AITC onto the dura mater caused a reduction in wheel running irrespective of acute morphine administration in rats pretreated with morphine (Fig. 1b, bottom) . There was no significant difference in the magnitude of wheel running during the first hour following AITC administration despite morphine administration [F(2, 21) = 0.68, NS].
The duration of AITC-induced depression of wheel running was prolonged in animals pretreated with morphine compared with those pretreated with THC or vehicle (Fig. 2) . AITC-induced depression of wheel running reverted to baseline levels by 4 h in rats pretreated with vehicle or THC, but remained depressed in rats pretreated with morphine [F(2, 29) = 3.78, P < 0.05].
Discussion
The present data show that administration of THC or morphine restores home cage wheel running depressed by AITC-induced migraine. THC was more effective than morphine both in the duration of antinociception and resistance to tolerance and MOH. Administration of THC restored wheel running for the entire 3-h duration of AITC-induced migraine and was as effective following the sixth injection as the first. In contrast, administration of morphine only restored wheel running for 1 h following the administration of AITC and this effect disappeared with repeated administration, as would be expected with the development of tolerance. In addition, repeated administration of morphine, but not THC, produced MOH, as indicated by prolonging AITCinduced depression of wheel running from 3 to 4 h. Activation of dural afferents by administration of AITC produced a consistent three-hour reduction in wheel running (Kandasamy et al., 2017c) . The restoration of home cage wheel running to baseline levels following the administration of THC is consistent with anecdotal reports of marijuana self-medication for migraine (Rhyne et al., 2016) . Marijuana may be an especially effective treatment, in that there was no evidence of tolerance or MOH with the doses or duration of administration used here. The lack of tolerance to THC contrasts with other studies examining the antinociceptive effects of THC to acute pain (Wakley et al., 2014) . Whether this difference in tolerance is a result of the different pain models used or the much larger doses and extended duration of administration in the previous study is not clear (Wakley et al., 2014) . The magnitude of tolerance to THC is greater with higher doses (McKinney et al., 2008) . The low doses used to restore wheel running may be advantageous in reducing the development of tolerance and limiting disruptive side effects. Our finding that tolerance does not occur to the administration of therapeutic doses of THC is consistent with clinical observations showing that tolerance is more likely to occur as the dose and frequency of use increase (González et al., 2005) .
Our finding that the administration of morphine caused a transient block of migraine-like pain is consistent with other rodent (Chanda et al., 2013) and human (Gallagher, 1986) data. Morphine and other opioids are used to treat severe cases of migraine, particularly when other agents are ineffective or contraindicated (Silberstein and Lipton, AITC-induced depression of wheel running is prolonged by repeated morphine administration. AITC-induced depression of wheel running lasted for 3 h in THC-treated (n = 8) and vehicle-treated (n = 14) rats. Repeated morphine administration (n = 8) prolonged the duration of AITC-induced depression of wheel running to 4 h. AITC, allyl isothiocyanate; BL, Baseline; THC, Δ 1994). The problem is that tolerance and MOH develop rapidly with repeated administration of morphine. In fact, morphine is not recommended as a standard migraine treatment because of the rapid development of MOH (Tepper, 2012) . Our data showing a lack of antinociception and prolonged AITC-induced depression of wheel running in rats receiving repeated morphine administration are consistent with the development of MOH. Whether this is a real model of MOH is difficult to determine because spontaneous pain is difficult to assess in animals. However, the prolonged duration of migrainelike pain suggests that this model may reflect MOH.
Conclusion
The present study shows that both THC and morphine are effective antimigraine treatments, but THC produces a more prolonged antinociception and one that is resistant to tolerance and MOH. These findings indicate that THC may be an especially effective long-term therapy for migraine patients.
